Under Armour Inc – Class C (UA): $5.07
Market Cap: $2.20B
Enterprise Value: $3.70B
Introduction
A few months ago, we wrote an Insider Weekends article about Madrigal Pharmaceuticals (MDGL), a biopharmaceutical company focused on treating metabolic dysfunction-associated steatohepatitis (MASH), a progressive liver disease. At the time, the company’s stock price was trading at $414.68, but in the few months since the article (and the associated insider purchases by the famous biotech investors, the Baker Bros), the company’s stock price has skyrocketed by over 60%.